Novadip

Regenerative Medicine
$11.2MTotal raised
Data updated Nov 21, 2026Money ledger: 1 record from 1 sourceAnnounced 1Full reportReport a mistake
Lately:1 news story in 90 daysFollow changes →

Facts

as of Nov 21, 2026

Novadip is committed to patients and addresses some of today’s biggest challenges in bone and tissue regenerative medicine.

Founded
2013
Official records
Wikidata Q30269210

These are the key facts about Novadip on Alion as of Nov 21, 2026. It was founded in 2013. The latest round is Venture - Series Unknown of $11.2M, announced in 2026.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

Novadip has $11.2M paid in by investors, lenders and donors.

$11.2MPaid in
Money innewest first
Equity raised · U.S
Oct 2026 · Venture round
$11.2MPaid
Money by yearUSD, rounds and grants
2026$11.2M1 record
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

Sources name U.S among the owners or investors of Novadip.

Named investors, no share stated1
U.S
Holders and shares as each register or filing states them.

Novadip in public registers.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Milestones

2013
Founded
Each milestone is dated by its source: registers, filings, the press

Newsroom

Oct 22026
News · Pulse 2.0
Novadip Biosciences has raised €10.4 million ($11.98 million) in convertible financing to advance its lead regenerative medicine program NVD003 through pivotal Phase 3 developmen…
Sources: the outlets named on each headline, each story once